pharmaphorum January 9, 2022
US medical device company Abbott has said it plans to launch a new range of ‘biowearable’ health devices aimed at consumers, in a move that builds on its expertise in glucose monitoring.
The company’s chief executive – Robert Ford – made the announcement at the massive CES tech trade show in Las Vegas, a venue usually dedicated to new TVs, gaming equipment, new smartphones and the like.
Given the ever-increasing convergence between tech and health, it’s somewhat remarkable that Abbott is the first ever health company to make a keynote presentation at CES.
“Health tech is at an inflection point, and COVID-19 has powerfully underscored the importance of health and the growing value of the technologies that protect and advance...
Today's Sponsors
Today's Sponsor